Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jade Ghosn

Showing results (141-150 of 267) with videos related to

Pageof 27
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|June 24, 2004
Virologic outcome after switching from a nucleoside reverse transcriptase inhibitor to tenofovir in patients with undetectable HIV-1 RNA plasma levelMarc Wirden, Anne Geneviève Marcelin, Roland Tubiana, et al.
Plos One|October 5, 2023
Investigating infectious outcomes in adult patients undergoing solid organ transplantation: A retrospective single-center experience, Paris, FranceHassan Tarhini, Rami Waked, Mayda Rahi, et al.
Antiviral Therapy|November 3, 2010
Unboosted atazanavir-based therapy maintains control of HIV type-1 replication as effectively as a ritonavir-boosted regimenJade Ghosn, Giampiero Carosi, Santiago Moreno, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2006
Risk factors for selection of the L74I reverse transcriptase mutation in human immunodeficiency virus type 1-infected patientsMarc Wirden, Bénédicte Roquebert, Anne Derache, et al.
AIDS (London, England)|March 9, 2022
Ibalizumab shows in-vitro activity against group A and group B HIV-2 clinical isolatesQuentin Le Hingrat, Gilles Collin, Antoine Bachelard, et al.
The Lancet Regional Health. Europe|November 11, 2024
Monkeypox clade IIb in France in 2023-2024Mayda Rahi, Sebastien Fouere, Marie Gilbert, et al.
The Lancet. HIV|October 2, 2015
Temporal trends in prognostic markers of HIV-1 virulence and transmissibility: an observational cohort studyNikos Pantazis, Kholoud Porter, Dominique Costagliola, et al.
The Journal of Antimicrobial Chemotherapy|May 30, 2015
Residual HIV-1 replication may impact immune recovery in patients on first-line lopinavir/ritonavir monotherapyTu-Anh Tran, Jade Ghosn, Véronique Avettand-Fenoël, et al.
The Journal of Antimicrobial Chemotherapy|November 2, 2017
CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virusJade Ghosn, Tatiana Bayan, Karolin Meixenberger, et al.
AIDS Research and Human Retroviruses|November 21, 2025
Bictegravir/Emtricitabine/Tenofovir Alafenamide in HIV-1-Infected Pregnant Women: Real-Life UseAntoine Bachelard, Zélie Julia, Florence Damond, et al.
Pageof 27

Showing results (141-150 of 267) with videos related to

Sort By:
Pageof 27
Journal of Acquired Immune Deficiency Syndromes (1999)|June 24, 2004
Virologic outcome after switching from a nucleoside reverse transcriptase inhibitor to tenofovir in patients with undetectable HIV-1 RNA plasma levelMarc Wirden, Anne Geneviève Marcelin, Roland Tubiana, et al.
Plos One|October 5, 2023
Investigating infectious outcomes in adult patients undergoing solid organ transplantation: A retrospective single-center experience, Paris, FranceHassan Tarhini, Rami Waked, Mayda Rahi, et al.
Antiviral Therapy|November 3, 2010
Unboosted atazanavir-based therapy maintains control of HIV type-1 replication as effectively as a ritonavir-boosted regimenJade Ghosn, Giampiero Carosi, Santiago Moreno, et al.
Antimicrobial Agents and Chemotherapy|June 28, 2006
Risk factors for selection of the L74I reverse transcriptase mutation in human immunodeficiency virus type 1-infected patientsMarc Wirden, Bénédicte Roquebert, Anne Derache, et al.
AIDS (London, England)|March 9, 2022
Ibalizumab shows in-vitro activity against group A and group B HIV-2 clinical isolatesQuentin Le Hingrat, Gilles Collin, Antoine Bachelard, et al.
The Lancet Regional Health. Europe|November 11, 2024
Monkeypox clade IIb in France in 2023-2024Mayda Rahi, Sebastien Fouere, Marie Gilbert, et al.
The Lancet. HIV|October 2, 2015
Temporal trends in prognostic markers of HIV-1 virulence and transmissibility: an observational cohort studyNikos Pantazis, Kholoud Porter, Dominique Costagliola, et al.
The Journal of Antimicrobial Chemotherapy|May 30, 2015
Residual HIV-1 replication may impact immune recovery in patients on first-line lopinavir/ritonavir monotherapyTu-Anh Tran, Jade Ghosn, Véronique Avettand-Fenoël, et al.
The Journal of Antimicrobial Chemotherapy|November 2, 2017
CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virusJade Ghosn, Tatiana Bayan, Karolin Meixenberger, et al.
AIDS Research and Human Retroviruses|November 21, 2025
Bictegravir/Emtricitabine/Tenofovir Alafenamide in HIV-1-Infected Pregnant Women: Real-Life UseAntoine Bachelard, Zélie Julia, Florence Damond, et al.
Pageof 27